Skip to search formSkip to main contentSkip to account menu

Non-Resectable Hepatocellular Carcinoma

A hepatocellular carcinoma that is not amenable to surgical resection.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Sorafenib is a small molecular inhibitor of intracellular tyrosine and serine/threonine protein kinases (VEGFR, PDGFR, CRAF and… 
2016
2016
Abstract Purpose The time course of changes of the liver function after stereotactic body radiotherapy (SBRT) was analyzed in… 
Highly Cited
2015
Highly Cited
2015
OBJECTIVES The optimal locoregional treatment for non-resectable hepatocellular carcinoma (HCC) of ≥ 3 cm in diameter is unclear… 
Highly Cited
2008
Highly Cited
2008
BackgroundThe objectives of this retrospective study was to evaluate the efficacy of stereotactic body radiation therapy (SBRT… 
2008
2008
OBJECTIVE To identify prognostic determinants of survival in patients with non-resectable hepatocellular carcinoma (HCC… 
2007
2007
BACKGROUND In a multidisciplinary conference patients with advanced non-resectable hepatocellular carcinoma (HCC) were stratified… 
2004
2004
SummaryAn assessment was made on the therapeutic effects of arterial chemotherapy and transcatheter arterial embolization (TAE… 
1988
1988
Phase II study of 5-fluorouracil (5-FU) and high dose folinic acid (HDFA) in hepatocellular carcinoma 
1986
1986
A group study was conducted to investigate the effect of intra-hepatic arterial administration of epirubicin in the treatment of…